TMS for Migraines

What is Migraine and How TMS Helps

Migraine isn’t just a bad headache. If you have one, you already know that. It’s a full neurological event — throbbing pain, nausea, light and sound turning hostile, and for about a third of people, those strange visual disturbances (aura) that announce what’s coming. Around 39 million Americans deal with this. Over a billion people worldwide.

Here’s what’s actually happening in your brain: a slow wave called cortical spreading depression (CSD) rolls across the brain’s surface — intense neuronal excitation followed by suppression. That wave triggers your trigeminal nerve system, inflames blood vessels around the brain, and dumps pain-signaling chemicals like CGRP (calcitonin gene-related peptide). If you get aura — shimmering lights, blind spots, zigzag patterns — that’s the CSD wave producing visual disturbances before the pain hits.

The usual treatment toolkit includes acute meds (triptans, NSAIDs, gepants) and preventives (beta-blockers, anticonvulsants, antidepressants, CGRP monoclonal antibodies). They work for many people. But side effects range from fatigue and brain fog to weight gain and rebound headaches from overuse. About 40% of people who should be on preventive treatment aren’t getting adequate relief from available medications.

TMS takes a completely different approach. A single magnetic pulse delivered to the back of the head disrupts that cortical spreading depression wave directly — stopping the migraine cascade at its neurological source before it produces pain. That mechanism makes TMS especially well-suited for migraine with aura, where CSD is the identifiable trigger.

How TMS Works for Migraines

TMS for migraine uses single-pulse technology (sTMS). This is different from the repetitive TMS (rTMS) used for depression. One brief magnetic pulse generates an electric field in the occipital cortex, depolarizes neurons, and interrupts the cortical spreading depression wave. CSD stops. The downstream trigeminal pain pathways never activate.

You place the device against the back of your head, over the occipital region where CSD originates. Press a button. A single pulse lasting less than one millisecond fires. That’s it. For acute treatment, you use it at the first sign of a migraine or aura. For prevention, you use it on a fixed daily schedule regardless of symptoms.

Acute Treatment Parameters

• Pulse type: Single pulse (sTMS)
• Placement: Occipital cortex (back of head)
• Timing: At migraine onset or during aura
• Dosing: 2-3 pulses per attack, with 15-second intervals
• Mechanism: Disrupts cortical spreading depression

Preventive Treatment Parameters

• Pulse type: Single pulse (sTMS)
• Schedule: 4 pulses twice daily (morning and evening)
• Placement: Occipital cortex
• Duration: Ongoing daily use
• Mechanism: Reduces cortical hyperexcitability over time

Researchers are also looking at repetitive TMS (rTMS) protocols for chronic migraine — clinic-based sessions targeting the motor cortex or DLPFC, similar to depression treatment. These aim to modulate pain processing networks rather than interrupt individual CSD events.

Clinical Evidence and Success Rates

The evidence here is strong, especially for acute treatment of migraine with aura. The pivotal ESPOUSE study — a large randomized controlled trial published in Cephalalgia in 2018 with 263 patients — showed:

• 39% of sTMS-treated patients were pain-free at 2 hours vs. 22% with sham (p = 0.018)
• 34% had sustained pain freedom at 24 hours without rescue medication
• 46% had pain relief (moderate/severe dropping to mild/none) at 2 hours

For context: oral triptans achieve 2-hour pain-free rates of roughly 25-35% across the class. And sTMS doesn’t come with triptan side effects like chest tightness, fatigue, or medication overuse headache. That’s a real advantage.

For prevention, the SPRING study followed 375 patients using daily sTMS and found a mean reduction of 2.75 migraine days per month versus sham. People with higher baseline frequency benefited most — those averaging 8+ migraine days per month saw reductions of 3-4 days.

The FDA first cleared the SpringTMS device (now sTMS mini by eNeura) for acute treatment of migraine with aura in 2013, then expanded clearance to include prevention and migraine without aura. That makes TMS one of very few drug-free, FDA-cleared options for migraine.

One note: the Nerivio device uses remote electrical neuromodulation, not magnetic stimulation. Different technology — don’t confuse the two.

Who Qualifies for TMS Treatment

TMS for migraine is FDA-cleared for anyone age 12 and older with migraine. The strongest results are in migraine with aura. People who benefit most include:

• Migraine with aura sufferers — the mechanism directly addresses cortical spreading depression, so this is the best-studied group
• People who want a drug-free option — if you’re worried about medication side effects, pregnant or breastfeeding, or can’t take triptans
• Those at risk for medication overuse headache — if you’re using acute meds more than 10-15 days a month and need to cut back
• Adolescents (age 12+) — the safety profile makes sTMS appealing for younger people where medication choices are more limited
• People whose meds aren’t working well enough — if you’ve tried 2+ preventive medications without real improvement

Contraindications: metallic implants in or near the head (dental work is fine), implanted magnetic-sensitive devices (cochlear implants, deep brain stimulators), and a personal history of epilepsy or seizures. Family history of seizures without personal seizure history? Generally safe.

No strict insurance prerequisites exist for sTMS, though some insurers want documentation of failed preventive medications before they’ll approve coverage.

What to Expect During Treatment

Here’s where migraine TMS is different from depression TMS: you use it at home. It’s a portable, handheld device. The process looks like this:

1. Physician evaluation: A neurologist or headache specialist confirms your migraine diagnosis and writes a prescription for the sTMS device
2. Device training: A brief session (in-office or virtual) teaches you how to position and operate it
3. Device delivery: The sTMS mini ships to your home or you pick it up from the prescribing office

For acute treatment: Feel a migraine starting — especially aura? Place the device against the back of your head, press the button. Deliver 2-3 pulses about 15 seconds apart. The whole thing takes less than 2 minutes. Timing matters: use it early, ideally during the aura phase before pain ramps up.

For prevention: Twice daily on a schedule — 4 pulses each time, morning and evening. Consistency is key. Preventive benefits build over weeks of regular use.

What does it feel like? A brief click and a mild tapping on the back of your head. Most people say it’s painless. No recovery time. Go right back to what you were doing.

Acute treatment works immediately, per attack. Preventive effects usually emerge over 4-8 weeks of consistent daily use, with continued improvement through 12 weeks.

Side Effects and Safety

Single-pulse TMS has one of the cleanest safety profiles of any migraine treatment. In trials involving over 1,000 patients, side effects were minimal:

• Lightheadedness: About 4% of users, lasting seconds to minutes
• Tingling at the application site: Mild and brief, in a small number of users
• Nausea: Rare, and usually from the migraine itself rather than the device

What you won’t get with sTMS — and this is the big selling point:

Seizure risk? Extremely low. Zero seizures have been reported in sTMS migraine trials. Single pulses carry far less cumulative excitatory effect than the repetitive protocols used for depression.

TMS Devices Used for Migraines

FDA-Cleared Devices

sTMS mini (eNeura): The primary FDA-cleared single-pulse TMS device for migraine. Portable, rechargeable, about 2.8 pounds, designed for home use. Cleared for both acute treatment and prevention in patients 12 and older. Available by prescription, usually through a monthly rental program.

Investigational Approaches

Repetitive TMS (rTMS) for chronic migraine: Several groups are studying clinic-based rTMS for people with chronic migraine (15+ headache days per month). These target the motor cortex or left DLPFC with high-frequency stimulation over 10-20 sessions. A 2021 meta-analysis of 7 rTMS studies found significant reductions in headache days and pain intensity — but this isn’t FDA-cleared yet.

Transcranial direct current stimulation (tDCS): Not TMS, but a related neuromodulation technology also being studied for migraine. Some neuromodulation clinics offer it alongside TMS.

Cost and Insurance Coverage

Migraine TMS costs work differently than depression TMS because the device is home-use, not clinic-based:

Insurance coverage for sTMS is variable and still evolving. Some commercial plans cover the device rental, especially if you’ve documented failure of multiple preventive medications. Medicare coverage varies by region.

How to improve your chances of coverage:

• Get a formal migraine with aura diagnosis documented by a neurologist — this has the strongest FDA clearance backing
• Document your medication trials — most insurers want evidence of 2-3 failed preventive medications
• Request prior authorization through your neurologist’s office before getting the device
• Appeal denials with clinical evidence — the ESPOUSE trial data and FDA clearance strengthen appeals
• Check manufacturer programs — eNeura has offered financial assistance and trial programs

Finding a TMS Provider

For migraine TMS, your main relationship is with the prescribing neurologist or headache specialist — not a TMS clinic. Here’s what matters:

• Board-certified neurologist or headache specialist — someone with headache medicine training who understands migraine and can determine whether TMS fits your overall treatment plan
• Experience prescribing neuromodulation devices — ask whether they’ve prescribed sTMS before and how many patients they currently manage on it
• Integrated migraine management — TMS works best as part of a broader approach including lifestyle changes, trigger management, and other treatments as needed
• Follow-up plan — a good provider schedules follow-ups to check your response and adjust strategy

If you’re interested in rTMS for chronic migraine (the investigational clinic-based approach), look for academic headache centers or pain clinics running research. ClinicalTrials.gov lists active studies — search “rTMS migraine” or “repetitive transcranial magnetic stimulation migraine.”

Frequently Asked Questions

Does TMS work for migraine without aura?

Yes, though the evidence is stronger for migraine with aura. The FDA clearance covers both types. Cortical spreading depression happens in migraine without aura too — it just doesn’t produce visible aura symptoms. Many people without aura do report benefit from sTMS, particularly for prevention.

Can I use TMS along with my migraine medications?

Absolutely. sTMS is safe alongside triptans, gepants, CGRP monoclonal antibodies, and preventive medications. A lot of people use TMS as their first-line acute treatment and keep medication as backup if the migraine breaks through. This can significantly cut overall medication use.

How quickly does TMS work during a migraine attack?

Fast — within minutes of pulse delivery. The catch is timing: using the device at the very first sign of a migraine or aura gives you the best results. Waiting until the headache is fully established makes it less effective.

Is TMS safe for children and teenagers with migraines?

The sTMS mini is FDA-cleared for patients 12 and older. Clinical data in adolescents shows a safety profile consistent with adults. For younger children, data is limited and use would be off-label, at the treating physician’s discretion.

Can TMS replace my preventive migraine medication?

For some people, daily sTMS provides enough preventive benefit to reduce or eliminate preventive meds. This should happen gradually, with your neurologist guiding the process. Others do best combining TMS with a reduced medication regimen. Talk to your neurologist before making changes.